MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'emory university'. Sat, 03 Sep 2011 02:12:20 +0100 http://www.medworm.com/index.php?rid=5158872&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F08%2Fquis-custodiet-ipsos-custodes-redux.html Revised HHS Rules for Conflict of Interest Fall Short This morning NIH Director Dr. Francis Collins announced revisions to the existing 1995 regulations on objectivity in research that is funded by the Public Health Service. The focus is on significant financial interests (SFI) and on financial conflicts of interest (FCOI). The regulations illustrate the 3-way dance involving academic institutions (the grantees), NIH (the grantor) and academic scientists (the investigators). Thanks to Senator Grassley (R-Iowa) and his investigator Paul Thacker, headlined revelations in recent years about unacceptable management of FCOI at places like Stanford (Alan Schatzberg), Emory (Charles Nemeroff) and Harvard (Joseph Biederman) forced these revisions of the NIH regulations. The general initial react... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=5158872 Tue, 23 Aug 2011 23:10:00 +0100 5158872 http://www.medworm.com/index.php?rid=4960330&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FeV33sONHAAI%2F Now you see recusal, now you don’t. For the past couple of years, National Institute of Mental Health director Tom Insel has found himself at the center of a furious controversy over conflicts of interest involving academic researchers who simultaneously receive NIH funding and do work for drugmakers. At one point, he was ensnared in a probe by the US Senate Finance Committee. What prompted this attention was a long-standing relationship with Charles Nemeroff, a former Emory University psychiatry department chair who accepted sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug. The revelation sparked a probe by the US Department of Health and Human Services Office of Inspector General. Ne... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4960330 Wed, 22 Jun 2011 13:32:59 +0100 4960330 http://www.medworm.com/index.php?rid=4536062&cid=t_168617_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fdetecting-circulating-tumor-cells-with-gold-nanoparticles%2F2011.03.02 Our modern armamentarium for treating cancer is impressive, but sometimes, despite our best treatments, tumor cells continue to lurk in the bloodstream, seeding metastases throughout the body. Researchers at Emory have developed a way to monitor for these circulating tumor cells using gold nanoparticles. This technique has been used before, but difficulty was encountered because white blood cells are close to the same size as some tumor cells, so they would both be tagged, necessitating a laborious multi-antibody staining process. “The key technological advance here is our finding that polymer-coated gold nanoparticles that are conjugated with low molecular weight peptides such as EGF are much less sticky than particles conjugated to whole antibodies,” says Shuming Nie, Ph.D., a profes... Better Health blogs http://www.medworm.com/rss/comments.php?id=4536062 Wed, 02 Mar 2011 14:00:03 +0100 4536062 http://www.medworm.com/index.php?rid=4372213&cid=t_168617_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F01%2F19%2Flibbys-hope%25e2%2584%25a2-proudly-announces-a-strategic-partnership-with-womens-oncology-research-dialogue%2F It is our privilege and honor to announce a strategic partnership between Libby’s H*O*P*E*™ and Women’s Oncology Research & Dialogue. It is our privilege and honor to announce a strategic partnership between Libby’s H*O*P*E*™ (LH) and Women’s Oncology Research & Dialogue (WORD). WORD’s overarching mission is to raise gynecologic cancer awareness and fund related scientific [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=4372213 Thu, 20 Jan 2011 01:22:53 +0100 4372213 http://www.medworm.com/index.php?rid=4241687&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F12%2Fimpeachment-its-about-institution-not.html IMPEACHMENT: IT’S ABOUT THE INSTITUTION, NOT THE PERSONThe impeachment trial of Judge G. Thomas Porteous of Louisiana this week was a lesson in civic ethics. The lessons of the Porteous trial apply to academic medical centers, professional medical societies, medical journals, and granting agencies like NIH. The Porteous trial is a straightforward case of bribes, kickbacks and corruption involving a Federal judge. The most enlightening arguments came from prosecutor Rep. Adam Schiff, D-California, laying out the case for impeachment in the Senate. He gave a lucid presentation of the logic and the historical origins of the impeachment process. The key points are these: impeachment serves to protect the dignity, honor, and credibility of the office more than to punish the wayward office hol... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=4241687 Wed, 08 Dec 2010 09:21:00 +0100 4241687 http://www.medworm.com/index.php?rid=4219791&cid=t_168617_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F12%2F01%2Fnemeroff-schatzberg-lend-names-to-ghostwritten-textbook%2F According to the Project On Government Oversight (POGO) and The New York Times, Dr. Charles B. Nemeroff, chairman of psychiatry at the University of Miami medical school since 2009 and Emory University before that, and Dr. Alan F. Schatzberg, the chairman of psychiatry at the Stanford University School of Medicine from 1991 until 2009 co-wrote a psychiatric textbook intended for primary care physicians — or did they? The book, Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care, has their names on it. But according to documents unearthed by the Project on Government Oversight, a Washington advocacy group, it was allegedly actually ghostwritten — at least in part — by a company called Scientific Therapeutics Information, Inc. ... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=4219791 Wed, 01 Dec 2010 12:23:58 +0100 4219791 http://www.medworm.com/index.php?rid=3943028&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fgy2YlHI1sNw%2F The ongoing probe of undisclosed conflicts of interest by the US Senate Finance Committee uncovered numerous instances involving academics, who simultaneously had ties to drugmakers while also conducting research that was funded by the National Institutes of Health. And a common thread among many of those who were probed was their work concerning psychiatric drugs, such as antidepressants and antipychotics (look here). So it probably should not come as a surprise that some of these people continue to pop up in various settings where they can hob-knob if they so choose. For those wishing to keep track of such things, Alan Schatzberg, who last week retired as chair of the psychiatry department at Stanford University (see the goodbye note here), is scheduled to appear during the Grand Rounds ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3943028 Tue, 07 Sep 2010 13:01:05 +0100 3943028 http://www.medworm.com/index.php?rid=3854747&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fda1v_H59wrU%2F Pharma lobbyists on Capitol Hill and academics at major universities may be rejoicing tonight at the news that Paul Thacker, an investigator for US Senator Chuck Grassley, is leaving to join the Project on Government Oversight, a non-profit watchdog, next month. No formal announcement was made, but his departure was disclosed in an email he distributed. During his three-year tenure, the former US Army specialist played a central role in the numerous investigations that examined prescription-drug safety and the undisclosed financial conflicts of interest involving academic researchers who simultaneously receive federal grants while doing work for drugmakers. In the process, Thacker and his colleagues prompted the National Institutes of Health and various universities to begin altering their... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3854747 Tue, 10 Aug 2010 21:56:49 +0100 3854747 http://www.medworm.com/index.php?rid=3806008&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F07%2Fcme-walk-down-memory-lane-charles.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3806008 Sat, 31 Jul 2010 03:18:00 +0100 3806008 http://www.medworm.com/index.php?rid=3737293&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FcDZXteAWacE%2F For the past several weeks, National Institute of Mental Health director Tom Insel has found himself at the center of a furious controversy over conflicts of interest involving academic researchers who simultaneously receive NIH funding and do work for drugmakers. An ongoing probe, meanwhile, by the Senate Finance Committee has made a poster boy of Charles Nemeroff, an old Insel colleague who recently landed a job as the psychiatry chair at the University of Miami med school. Insel was caught up in this affair, because he spoke with the med school dean Pascal Goldschmidt, who asked for a reference before hiring Nemeroff, who was working at Emory University when the Senate committee learned of the large consulting fees he received from GlaxoSmithKline. The query from Goldschmidt was made ju... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3737293 Thu, 08 Jul 2010 14:14:41 +0100 3737293 http://www.medworm.com/index.php?rid=3710795&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FYYomDF92Fdo%2F For those tracking the ongoing investigation by the Senate Finance Committee investigation into conflicts of interest among academic researchers and industry funding, Charles Nemeroff was one of the targets. The former Emory University professor, who now works at the University of Miami, came to the committee’s attention because he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug. The Senate investigation, spearheaded by Chuck Grassley, the Iowa Republican, prompted Emory to suspend Nemeroff’s work on an NIH grant and asked him to step down as chair of psychiatry while it studied his conduct. And the Department of Health and Human Services Office of Inspector General began ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3710795 Tue, 29 Jun 2010 14:00:58 +0100 3710795 http://www.medworm.com/index.php?rid=3695810&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6eIRDd_IgcA%2F In August, the Georgia Psychiatric Physicians Association will hold a three-day continuing medical education meeting at the Ponte Vedra Inn & Club in Florida, where the discussions will focus on issues surrounding bipolar disorder and obsessive compulsive disorder, among other things. One of the featured speakers will be Charles Nemeroff, the recently hired psychiatry chair at the University of Miami medical school, who also has become a sort of poster child for the controversy over undisclosed financial conflicts among academic researchers who accept federal grants while also doing work for drugmakers (see here, here and here). In Nemeroff’s case, his infractions occurred while he worked at as a professor at Emory University in Atlanta. Interestingly, his bio for the upcoming e... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3695810 Thu, 24 Jun 2010 13:20:16 +0100 3695810 http://www.medworm.com/index.php?rid=3648800&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fjrz55Ui52oM%2F As the National Institutes of Health grappled last year with an ongoing Senate probe into financial conflicts of interest involving academic researchers who accept federal grants and industry funding, Tom Insel downplayed the need for a “COI shop” devoted to handling the problem. Insel, you may recall, heads the National Institutes of Mental Health, and helped lead the NIH regulatory review process that recently proposed new rules for monitoring conflicts of interest (see this). His view was expressed in a May 6, 2009, e-mail to colleagues who asked about hiring someone to help with COI issues that have been “swamping me,” as one wrote in a different e-mail the same day (you can read them here). Insel wasn’t persuaded. “I think there are more urgent need... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3648800 Thu, 10 Jun 2010 11:56:10 +0100 3648800 http://www.medworm.com/index.php?rid=3645051&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fq_WzjKK7fpY%2F How close are Tom Insel, the National Institutes of Mental Health director, and Charles Nemeroff, a former Emory University professor who has been the focus of an ongoing Senate probe into financial conflicts of interest among academic researchers? A recent story in The Chronicle of Higher Education noted that Insel (see photo) “quietly” helped Nemeroff get a new job last fall at the University of Miami School of Medicine, which overlooked a two-year ban Emory imposed on Nemeroff for receiving federal grants (back story). This prompted US Senator Chuck Grassley to extend his probe still more (see this). The ties beween the two men, which reportedly go back a few years, appeared to be on display in a series of emails (see them here). One e-mail from Nemeroff to Insel last Octobe... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3645051 Wed, 09 Jun 2010 14:49:36 +0100 3645051 http://www.medworm.com/index.php?rid=3644984&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F06%2Fpublic-trust-does-matter-national.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3644984 Wed, 09 Jun 2010 02:01:00 +0100 3644984 http://www.medworm.com/index.php?rid=3641321&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrYivhU7sae4%2F The Charles Nemeroff affair encompasses more people all the time. Now, the University of Miami Medical School has become ensnared in the ongoing probe launched by US Senator Chuck Grassley, who investigated Nemeroff as part of an inquiry into undisclosed financial conflicts of intereest among academic researchers who receive federal grants. You may recall Nemeroff, who was recently hired by the University of Miami, had departed Emory University after the Senate probe disclosed he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (see this). Before his departure, Emory imposed a two-year ban on grants for on Nemeroff. This week, however, the U of Miami med school head, Pascal Gol... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3641321 Tue, 08 Jun 2010 15:44:41 +0100 3641321 http://www.medworm.com/index.php?rid=3636020&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fey5jUPYG6Hs%2F For the past two years, the National Institutes of Health has been pressured by Congress to do a better job of monitoring conflicts of interest in which academic researchers accept funding from the agency and drugmakers. At issue is the concern that key research and subsequent studies will unduly influence treatment, and so the NIH recenty proposed tougher rules (see this). Earlier this year, the US Senate Finance Committee extended its scrutiny to Tom Insel, the director of the National Institutes of Mental Health (see photo), given that many conflicts involved academic psychiatrists and drugmakers that market antidepressants and antipsychotics (see this). Now, The Chronicle of Higher Education peels back an interesting, long-running relationship between Insel and one of the more notoriou... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3636020 Mon, 07 Jun 2010 13:21:25 +0100 3636020 http://www.medworm.com/index.php?rid=3420753&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FObN8CO51qgA%2F For those tracking the ongoing investigation by the Senate Finance Committee investigation into conflicts of interest among academic researchers and industry funding, Charles Nemeroff was one of the targets. The former Emory University professor, who now works at the University of Miami, came to the committee’s attention because he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug. The Senate investigation, spearheaded by Chuck Grassley, the Iowa Republican, prompted Emory to suspend Nemeroff’s work on an NIH grant and asked him to step down as chair of psychiatry while it studied his conduct. And the Department of Health and Human Services Office of Inspector General be... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3420753 Tue, 30 Mar 2010 14:26:41 +0100 3420753 http://www.medworm.com/index.php?rid=3267189&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F02%2Fdr-doug-bremner-emory-university-fox.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3267189 Fri, 12 Feb 2010 06:44:00 +0100 3267189 http://www.medworm.com/index.php?rid=3251378&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F02%2Fdoug-bremner-accutane-and-depression.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3251378 Mon, 08 Feb 2010 15:28:00 +0100 3251378 http://www.medworm.com/index.php?rid=3142834&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FBV510ElTxc0%2F Yesterday, we wrote that Charles Nemeroff, the controversial psychiatry professor at Emory University in Atlanta, had just purchased a $1.9 million, six-bedroom, seven-bath home in the Coconut Grove section of Miami, as he prepares for his new job at the University of Miami’s Miller School of Medicine, where he’ll chair the psychiatry department. For those who were wondering about his home in Atlanta, you won’t be surprised that it’s up for sale and the going rate is $1.25 million. You can take a tour here. This one sports just five bedrooms, but still plenty of room for storing consulting materials. Nemeroff wound up in the spotlight thanks to the US Senate Finance Committee, which is trying to force universities and the NIH to more aggressively monitor alleged con... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3142834 Tue, 05 Jan 2010 12:19:27 +0100 3142834 http://www.medworm.com/index.php?rid=3142817&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F01%2Fcharles-nemeroffs-19-million-dollar.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3142817 Mon, 04 Jan 2010 16:48:00 +0100 3142817 http://www.medworm.com/index.php?rid=3139247&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FQyW535HY1m8%2F Charles Nemeroff, the controversial psychiatry professor who became a subject of a US Senate Finance Committee inquiry into academic research and pharma industry influence, is joining the University of Miami’s Miller School of Medicine. Of course, this means leaving his previous job at Emory University in Atlanta and so he’s just purchased a $1.9 million house in the Coconut Grove section of Miami. The 5,204-square-foot home has six bedrooms and seven bathrooms, according to BlockShopper. Nemeroff, you may recall, came to the Senate committee’s attention because he was accepting sizeable consulting fees from Glaxo at the same that he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (you can read background here and here). Chuck Grassley, an I... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3139247 Mon, 04 Jan 2010 12:53:50 +0100 3139247 http://www.medworm.com/index.php?rid=3063458&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F12%2Fcme-outfitters-biased-cme-program.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=3063458 Sun, 06 Dec 2009 22:49:00 +0100 3063458 http://www.medworm.com/index.php?rid=2959076&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FVYC8IoMgLe4%2F In a Nov. 2 email, the university’s president, Donna Shalala, reminds faculty that “integrity is the very bedrock of our institution and the foundation for the trust that students, patients, academic colleagues, and society place in us.” And so she provides an update on an initiative to refine the rules about conflicts of interest, transparency and ethics, which can be found in this handbook. Among the recent steps she outlined: the university has established a central database that houses faculty disclosure forms (and 93 percent have filed so far); added detailed disclosure forms for all key personnel as well as faculty on federal grants; implemented an ongoing assessment and improvement of policies to address conflicts of interest, and there are plans to “enhance ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2959076 Wed, 04 Nov 2009 13:09:52 +0100 2959076 http://www.medworm.com/index.php?rid=2944100&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fidjr0WaSrfA%2F The controversial psychiatry professor, who was among several high-profile academics targeted by a Senate Finance Committee probe into conflicts of interest involving NIH and industry funding, is taking a new job - chair of the psychiatry department at the Miller School of Medicine at The University of Miami, according to sources familiar with the school. You may recall that Nemeroff, who currently works at Emory University, came to the Senate committee’s attention because he was accepting sizeable consulting fees from Glaxo at the asme that he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (you can read background here and here). Chuck Grassley, an Iowa Repulican who spearheaded the Senate probe, is trying to force universities and the NIH to more... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2944100 Thu, 29 Oct 2009 12:56:04 +0100 2944100 http://www.medworm.com/index.php?rid=2939557&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fidjr0WaSrfA%2F The controversial psychiatry professor, who was among several high-profile academics targeted by a Senate Finance Committee probe into conflicts of interest involving NIH and industry funding, is being considered for a new job - chair of the psychiatry department at the Miller School of Medicine at The University of Miami, according to sources familiar with the school. You may recall that Nemeroff, who currently works at Emory University, came to the Senate committee’s attention because he was accepting sizeable consulting fees from Glaxo at the asme that he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (you can read background here and here). Chuck Grassley, an Iowa Repulican who spearheaded the Senate probe, is trying to force universities and t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2939557 Thu, 29 Oct 2009 12:56:04 +0100 2939557 http://www.medworm.com/index.php?rid=2882995&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F10%2Fnemeroff-seroquel-and-accme.html Roy Poses has discussed the atypical antipsychotic drug Seroquel (quetiapine) several times on this site, pointing out manipulation of clinical research results to enhance the appearance of efficacy, and suppression of studies with unfavorable results. I call this augmenting the marketed profile of the drug. Daniel Carlat has commented on published Seroquel data here and ClinPsych here.AstraZeneca, the marketer of Seroquel, has also been busy with continuing medical education (CME) programs that augment Seroquel’s profile. Last December 8, one such program went on line, aired by the provider CME Outfitters. The program’s title was “Atypical Antipsychotics in Major Depressive Disorder: When Current Treatments Are Not Enough.” The corporate logo for CME Outfitters is Education with I... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2882995 Mon, 12 Oct 2009 05:32:00 +0100 2882995 http://www.medworm.com/index.php?rid=2883202&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F10%2Fpharmalot-flashback-nemeroff-removed-as.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2883202 Mon, 12 Oct 2009 00:39:00 +0100 2883202 http://www.medworm.com/index.php?rid=2834464&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F09%2Fgsk-paxil-birth-defects-court-documents_25.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2834464 Fri, 25 Sep 2009 22:41:00 +0100 2834464 http://www.medworm.com/index.php?rid=2828446&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F09%2Fgrady-clinic-in-alanta-georgia-refuses.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2828446 Wed, 23 Sep 2009 22:09:00 +0100 2828446 http://www.medworm.com/index.php?rid=2809880&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F09%2Fdrdaniel-carlatpaul-thacker-tenacious.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2809880 Fri, 18 Sep 2009 23:52:00 +0100 2809880 http://www.medworm.com/index.php?rid=2725245&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F08%2Feffexor-withdrawals-nemeroff-celebrated.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2725245 Fri, 21 Aug 2009 18:36:00 +0100 2725245 http://www.medworm.com/index.php?rid=2611157&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Fmothers-act-disease-mongering-campaign.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2611157 Thu, 16 Jul 2009 19:02:00 +0100 2611157 http://www.medworm.com/index.php?rid=2611158&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Fjohn-grohol-says-bremner-isnt-banned.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2611158 Thu, 16 Jul 2009 13:11:00 +0100 2611158 http://www.medworm.com/index.php?rid=2606203&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Fpsych-central-blog-censors-drdoug.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2606203 Thu, 16 Jul 2009 05:15:00 +0100 2606203 http://www.medworm.com/index.php?rid=2606204&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Fdrdoug-bremner-motherhood-is-not.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2606204 Wed, 15 Jul 2009 18:46:00 +0100 2606204 http://www.medworm.com/index.php?rid=2591684&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Fharvard-professor-starts-non-profit.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2591684 Sat, 11 Jul 2009 07:29:00 +0100 2591684 http://www.medworm.com/index.php?rid=2591686&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Femory-university-bans-professor-from_10.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2591686 Sat, 11 Jul 2009 00:08:00 +0100 2591686 http://www.medworm.com/index.php?rid=2786020&cid=t_168617_109_f&fid=38951&url=http%3A%2F%2Fcarlatpsychiatry.blogspot.com%2F2009%2F07%2Fnote-to-emory-modest-proposal.html In support of Dr. Doug Bremner, blogger supreme and Professor of Psychiatry and Radiology at Emory Medical School, I hereby proclaim my own academic affiliation--namely, Associate Clinical Professor of Psychiatry at Tufts University School of Medicine.Recently, Emory University forced Dr. Bremner to remove its name from his blog because they didn't like things that he had to say. This has resulted in two things: First, Dr. Bremner's blog quadrupled in popularity, and second, Emory is in the midst of yet another PR fiasco. See yesterday's article in Emory's online newsletter Academic Exchange for a good rundown of this issue.Here's my modest proposal. Between its poor handling of the Charles Nemeroff scandal and now its fumbling over Bremner, Emory should relinquish the use of its own name ... The Carlat Psychiatry Blog blogs http://www.medworm.com/rss/comments.php?id=2786020 Fri, 10 Jul 2009 10:53:00 +0100 2786020 http://www.medworm.com/index.php?rid=2588422&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Femory-university-school-of-medicine.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2588422 Thu, 09 Jul 2009 15:39:00 +0100 2588422 http://www.medworm.com/index.php?rid=2584370&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Femory-university-bans-professor-from_09.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2584370 Thu, 09 Jul 2009 08:23:00 +0100 2584370 http://www.medworm.com/index.php?rid=2573082&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Femory-university-bans-professor-from_05.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2573082 Mon, 06 Jul 2009 00:50:00 +0100 2573082 http://www.medworm.com/index.php?rid=2571174&cid=t_168617_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F07%2Femory-university-bans-professor-from.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2571174 Sat, 04 Jul 2009 16:13:00 +0100 2571174 http://www.medworm.com/index.php?rid=2570444&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F07%2Fblogger-that-dares-not-speak-his.html Dr Douglas Bremner is a Professor of Psychiatry and Radiology at Emory University, and Director of the University's Clinical Neuroscience Research Unit. He has also written a book critical of the pharmaceutical industry (Before You Take That Pill), and writes a blog (also called Before You Take That Pill) that is also skeptical about certain aspects of current psychiatric dogma. Inside Higher Education reported that Emory University can apparently no longer bear to have its name mentioned in Dr Bremner's blog:Emory University has been accused repeatedly over the last year of looking the other way while one of its prominent physicians built extremely close ties to the pharmaceutical industry and -- critics charge -- failed to adequately report those ties as required by university and federa... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2570444 Fri, 03 Jul 2009 19:26:00 +0100 2570444 http://www.medworm.com/index.php?rid=2375958&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F04%2Finstitute-of-medicine-report-on.html Today we saw a new marker laid down in the arena called Conflict of Interest (COI). The Institute of Medicine of the National Academy of Sciences issued a report of its Committee on Conflict of Interest in Medical Research, Education and Practice. The report is comprehensive, even exhaustive, running to 353 pages. Gardner Harris in the New York Times today calls it “scolding,” “stinging,” and “damning.” The recommendations go well beyond any proposed in the recent past by medical schools or by other professional organizations. The NYT quoted David Rothman, president of the Institute on Medicine as a Profession at Columbia University: “With the I.O.M.’s endorsement, issues that were once controversial now are indisputable. Conflicts of interest in medicine are no longer acce... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2375958 Wed, 29 Apr 2009 00:40:00 +0100 2375958 http://www.medworm.com/index.php?rid=2053203&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F488916084%2F We all need reminders once in a while, but Emory Univeristy psychiatry professor Charles Nemeroff had an unusual way of generating one. On February 9, 2000, he wrote himself an invitation on the letterhead of the Depression and Anxiety journal, which he edited at the time, to write an article to celebrate the 5th anniversary of the introduction of Wyeth’s Effexor antidepressant. For his trouble, Nemeroff offered to pay himself a $3,000 fee, although some handwriting scribbled on the letter indicates Kerry Ressler was later invited to co-author the manuscript and the fee would be split. Moreover, an attached invoice indicates Nemeroff was actually to receive a total of $4,500 - $3,000 for organizing the ‘honorarium’ and $1,500, or half of the fee for the manuscript. Accord... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2053203 Thu, 18 Dec 2008 18:53:42 +0100 2053203 http://www.medworm.com/index.php?rid=2053204&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F488864331%2F We all know there are nuances and subtleties in life. There are also torturous tongue-tied moments when explanations give the impression one is reaching. And that is what Chuck Grassley accuses Emory University of doing in trying to explain away the assorted consulting work reknowned psychiatry professor Charles Nemeroff did on behalf of Glaxo and its drugs, notably the Paxil antidepressant. Nemeroff, you may recall, is being investigated by the US Senate Finance, where Grassley is the ranking Republican, for alleged conflicts of interest for simultaneously receiving NIH grants and consulting for pharma. He earned more than $2.8 million from various drugmakers between 2000 and 2007, but failed to report at least $1.2 million of this income to the university (back story here and here). At i... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2053204 Thu, 18 Dec 2008 17:49:14 +0100 2053204 http://www.medworm.com/index.php?rid=1906169&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F429566227%2F Andrew Witty wants to board the transparency train. After a few rival drugmakers - such as Lilly and Merck - vowed to disclose payments to doctors, Glaxo is now saying it will do the same. And so the ceo promises to make public the level of advisory fees it offers to doctors and medical academics, and will strictly cap the payments they can receive in the US to $150,000 a year, according to The Financial Times. He tells the paper that he will impose a cap “without exception” on payments and promised to publish the amounts. Although, a timetable has not been revealed. [Our thought: $150,000 is a lot of money, Andrew. Why so much?] The move comes after Glaxo has been caught up in pair of publicized debacles. In the US, Charles Nemeroff received about $1 million in payments from G... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1906169 Thu, 23 Oct 2008 12:03:07 +0100 1906169 http://www.medworm.com/index.php?rid=1880155&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F420881785%2F The NIH has frozen a $9.3 million, five-year grant to Emory University in response to an investigation by the US Senate Finance Committee into alleged conflicts of interest among academic researchers who receive government grants and also do work for drugmakers (this is the grant). The move, which was first reported by The Atlanta Journal-Constitution, comes after Charles Nemeroff (pictured left) stepped down as chair of the Emory psychiatry department. Nemeroff is being investigated for earning more than $2.8 million in consulting arrangements with various drugmakers between 2000 and 2007, but failed to report at least $1.2 million of this income to the university. At issue is whether universities are adequately policing disclosures in an effort to maintain scientific integrity and object... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1880155 Tue, 14 Oct 2008 20:02:36 +0100 1880155 http://www.medworm.com/index.php?rid=1876477&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F419855423%2F In the wake of the investigation by the US Senate Finance Committee into Emory University psychiatry professor Charles Nemeroff, the National Institutes of Health is now imposing new conditions before agreeing to award grants to the university, according to an October 10 memo sent to faculty. An NIH regulation requires researchers to report to their universities any “significant financial interests” they hold in research financed by the agency - defined as income or equity interest of $10,000 from a company or 5-percent ownership of its stock. The universities are required to tell the NIH whether they were able to manage or eliminate the conflicts in order to avoid bias in the research findings. The committee is investigating Nemeroff’s alleged failure to fully disclose payments ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1876477 Mon, 13 Oct 2008 20:31:17 +0100 1876477 http://www.medworm.com/index.php?rid=1873028&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2008%2F10%2Fnemeroff-case-vs-anechoic-effect.html The saga of Dr Charles Nemeroff was most recently discussed on Health Care Renewal here and here. We had first posted about his failure to disclose relevant conflicts of interest relating an article he wrote for a journal he also edited here. Other posts about Nemeroff's questionable behavior are here, here. Nemeroff has also starred in numerous posts on the Clinical Psychology and Psychiatry Blog, amongst others.Now the tale of how Nemeroff raked in hundreds of thousands of dollars as a paid speaker on behalf of drug marketers, and denied these earnings while he ran a US government funded project meant to evaluate some of the products of his commercial sponsors, has splashed across major newspapers. There has been a lot of good discussion about the case in the blogsphere. (We await, of co... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=1873028 Mon, 13 Oct 2008 19:50:00 +0100 1873028 http://www.medworm.com/index.php?rid=1871104&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F416746621%2F For the past several months, the US Senate Finance Committee has been investigating undisclosed conflicts of interest involving academic researchers who receive NIH grants and pharma funding. At issue is whether universities are fulfilling their requirements to adequately monitor these disclosures in an effort to maintain scientific integrity and objectivity (back story here, here, here, here and here. Nature Medicine spoke with Chuck Grassley, the ranking Republican on the committee, about the probe. This is an excerpt… Nature Medicine:What are you hoping to accomplish? Grassley: NIH gives $24 billion worth of grants…The law requires the universities to have their researchers report outside income. We found out the law wasn’t being followed. The universities were not doi... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1871104 Fri, 10 Oct 2008 12:23:26 +0100 1871104 http://www.medworm.com/index.php?rid=1859465&cid=t_168617_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2008%2F10%2Fthoughts-on-charles-nemeroffs-not-so.html The saga of Dr Charles Nemeroff was most recently discussed on Health Care Renewal here. We had first posted about his failure to disclose relevant conflicts of interest relating an article he wrote for a journal he also edited here. Other posts about Nemeroff's questionable behavior are here, here. Nemeroff has also starred in numerous posts on the Clinical Psychology and Psychiatry Blog, amongst others.Now the tale of how Nemeroff raked in hundreds of thousands of dollars as a paid speaker on behalf of drug marketers, and denied these earnings while he ran a US government funded project meant to evaluate some of the products of his commercial sponsors, has splashed across major newspapers. There has been a lot of good discussion about the case in the blogsphere. (We await, of course, dis... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=1859465 Tue, 07 Oct 2008 21:19:00 +0100 1859465 http://www.medworm.com/index.php?rid=1859770&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F413099718%2F Ever play ‘Whack-A-Mole?’ You know, you smack the little creature on the head whenever it pops up, although it keeps reappearing elsewhere? Well, Emory University’s Charles Nemeroff, who is the latest academic researcher to be investigated by the US Senate Finance Committee for undisclosed conflicts of interest, managed to pop up in all sorts of venues as a speaker over the past few years. If you look at this schedule, which runs from 2000 to 2006, the nationally known psychiatrist, who until Friday night chaired the Emory School of Medicine psychiatry department, was a fixture on the Glaxo speaking circuit for such drugs as Paxil and Wellbutrin. There he is at the Bacara Resort & Spa in Santa Barbara, California, talking up Paxil CR. Here him chat at the Peninsula G... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1859770 Mon, 06 Oct 2008 20:05:52 +0100 1859770 http://www.medworm.com/index.php?rid=1853828&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F412282361%2F For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the primary investigator on an NIH-funded grant for research into a Glaxo drug. Why? Since 1995, an NIH regulation has required scientists to report to their universities any “significant financial interests” they hold in research projects financed by the agency. Those are defined as income or equity interest of $10,000 from a company or 5-percent ownership of its stock. The universities, in turn, are required to tell the NIH whether they were able to manage or eliminate the conflicts in order to avoid bias in the research findings (here are the rules). And anxious Emory officials, who condu... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1853828 Mon, 06 Oct 2008 00:37:31 +0100 1853828 http://www.medworm.com/index.php?rid=1852733&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410799481%2F The move by well-known psychiatrist Charles Nemeroff comes in response to the investigation by the Senate Finance Committee into allegations of undisclosed conflicts of interest, according to an e-mail written by Claudia Adkison, an Emory University associate dean. At issue is whether universities are adequately policing disclosures in an effort to maintain scientific integrity and objectivity. The committee is investigating up to 30 academic psychiatrists who allegedly accepted grants from the NIH and pharma, but failed to properly report payments, which universities are required to monitor. The NIH is being leaned on to yank grants when disclosure is inadequate. So far, the committee has singled out Stanford University’s Alan Schatzberg, Harvard University’s Joe Biederman, B... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1852733 Sat, 04 Oct 2008 03:49:22 +0100 1852733 http://www.medworm.com/index.php?rid=1852735&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410489215%2F The reason - the psychiatry department chair at Emory University earned more than $2.8 million in consulting arrangements with various drugmakers between 2000 and 2007, but failed to report at least $1.2 million of this income to his university. This oversight violated federal research rules, a point that is central to a widening probe of some 30 academic researchers by the Senate Finance Committee. Since yesterday, we have twice posted items indicating Charles Nemeroff and Emory were caught up in the investigation (look here and here). Now, The New York Times has revealed a detailed account. For instance, the paper writes that Nemeroff signed a letter dated July 15, 2004, promising Emory administrators that he would earn less than $10,000 a year from Glaxo to comply with federal rules. B... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1852735 Fri, 03 Oct 2008 18:41:15 +0100 1852735 http://www.medworm.com/index.php?rid=1852738&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410375229%2F Why was Charles Nemeroff, the well-known psychiatry department chair at Emory University, anxious about an e-mail from The New York Times in August? Could it be that word had leaked Emory was concerned about an ongoing probe by the Senate Finance Committee into disclosures of NIH and pharma funding to academic researchers? Was Nemeroff next? By then, the committee was investigating Stanford University’s Alan Schatzberg, Harvard University’s Joe Biederman, Brown University’s Martin Keller, University of Texas’ Karen Wagner and John Rush, and Melissa DelBello at the University of Cincinnati. Yesterday, we noted Nemeroff wrote an angry memo to the associate dean at Emory’s School of Medicine, who questioned pharma ties to an annual event he runs for psychiatry re... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1852738 Fri, 03 Oct 2008 15:55:23 +0100 1852738 http://www.medworm.com/index.php?rid=1851212&cid=t_168617_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F409343727%2F The ongoing investigation by the Senate Finance Committee seems to be making some universities a bit, well, sensitive to the activities undertaken by faculty members. You may recall that Chuck Grassley, the commitee’s ranking Republican, is probing pharma and NIH funding given academic researchers - particularly psychiatrists - and whether any conflicts are properly disclosed. So far, the committee has singled out Stanford University’s Alan Schatzberg, Harvard University’s Joe Biederman, Brown University’s Martin Keller, University of Texas’ Karen Wagner and John Rush, and Melissa DelBello at the University of Cincinnati. Charles Nemeroff, the well-known psychiatry chairman at Emory University, has not made the list, but the school appears, nonetheless, to be ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1851212 Thu, 02 Oct 2008 15:19:44 +0100 1851212 http://www.medworm.com/index.php?rid=1215697&cid=t_168617_122_f&fid=36582&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F231123917%2F Not a day goes by without a significant depression-related announcement. Yesterday, one could read that Older Women More Likely to Suffer Depression (than Older Men; in the Washington Post). Today, we see that St. Jude Starting Trial On Brain Stimulation For Depression (CNN). A few days ago, Blue Cross of California Launched Maternity Depression Program (press release). Time to step back and ask ourselves questions such as, "What is going On", "What is Depression", "What Treatments Work, and What is the Latest Research". Fortunately, thanks to our collaboration with Greater Good Magazine, Jill Suttie offers a fascinating answers to those questions-and more. Enjoy. --------------------------- Closing the Circuit Helen Mayberg's research could revolutionize ... SharpBrains blogs http://www.medworm.com/rss/comments.php?id=1215697 Thu, 07 Feb 2008 18:10:34 +0100 1215697 http://www.medworm.com/index.php?rid=675452&cid=t_168617_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F06%2F14%2Fnumbers-game-predicting-risk-for-type-2-diabetes%2F This study took a 3,140-strong sample of middle-age persons, identifying them as having an average age of fifty-four, the majority overweight and over twelve percent exhibiting pre-diabetic blood sugar irregularities. Critical personal data for each patient (height, weight etc.) was recorded, then clinical models were developed through the addition of metabolic syndrome traits - that is, conditions increasing the risk for cardio trouble etc. All of this data was combined with results of the patients' responses to tests (such as the fasting insulin test). From this mass of data, these incredible people were able to pull the following fact: simple tests are all that are needed to predict Type 2 diabetes risk in middle-age. That is, basic personal variables such as whether or not you are obes... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=675452 Thu, 14 Jun 2007 04:00:00 +0100 675452